Search Within

Matthew David Hellmann

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (43)
  2. Meeting Abstract (25)
  3. Research Letter (1)
Groups
  1. Department of Medicine (69)
  2. Human Oncology and Pathogenesis Program (69)
  3. Solid Tumor Oncology Division (69)
  4. Thoracic Oncology (69)
  5. GSK Faculty (68)
  6. Department of Pathology and Laboratory Medicine (60)

More Groups

People
  1. Marc Ladanyi (49)
  2. Charles Rudin (42)
  3. Gregory Riely (34)
  4. Mark Kris (32)
  5. Maria Arcila (28)
  6. Hira Rizvi (27)

More People

Years
  1. 2024 (3)
  2. 2023 (7)
  3. 2022 (10)
  4. 2021 (4)
  5. 2020 (7)
  6. 2019 (12)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Journal of Thoracic Oncology (8)
  3. Clinical Cancer Research (7)
  4. Annals of Oncology (6)
  5. JCO Precision Oncology (4)
  6. Nature (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (12)
  3. Nature Publishing Group (10)
  4. Elsevier Inc. (8)
  5. Oxford University Press (8)
  6. Cell Press (3)

More Publishers

Results (69)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals clinically-relevant subsets with small cell carcinoma-like and non-small cell carcinoma-like molecular profiles
    Meeting Abstract

    Rekhtman, N.; Naidoo, J.; Pietanza, M.; Hellmann, M. D.; Arora, A.; Shen, R. L.; Halpenny, D. F.; Won, H.; Berger, M. F.; Tian, S. Z.; more...
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals clinically-relevant subsets with small cell carcinoma-like and non-small cell carcinoma-like molecular profiles
    Meeting Abstract

    Rekhtman, N.; Naidoo, J.; Pietanza, M.; Hellmann, M. D.; Arora, A.; Shen, R.; Halpenny, D. F.; Won, H.; Berger, M. F.; Tian, S.; more...
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Impact of concurrent PIK3CA mutations on response to EGFR tyrosine kinase inhibition in EGFR-mutant lung cancers and on prognosis in oncogene-driven lung adenocarcinomas
    Journal Article

    Eng, J.; Woo, K. M.; Sima, C. S.; Plodkowski, A.; Hellmann, M. D.; Chaft, J. E.; Kris, M. G.; Arcila, M. E.; Ladanyi, M.; Drilon, A.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Prevalence of germline BAP1 mutations in patients with malignant mesothelioma (MM)
    Meeting Abstract

    Hellmann, M. D.; Borsu, L.; Zehir, A.; Cheng, D. T.; Zha, Z.; Siegel, B.; Rohrer, R. W.; Robson, M. E.; Arnold, A. G.; Fleischut, M. H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas
    Meeting Abstract

    Eng, J.; Hellmann, M. D.; Woo, K.; Sima, C. S.; Yu, H. A.; Arcila, M. E.; Ladanyi, M.; Kris, M. G.; Drilon, A. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers
    Meeting Abstract

    Drilon, A. E.; Hellmann, M. D.; Wang, L.; Cho, E. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical characteristics and course of 63 patients with BRAF mutant lung cancers
    Journal Article

    Litvak, A. M.; Paik, P. K.; Woo, K. M.; Sima, C. S.; Hellmann, M. D.; Arcila, M. E.; Ladanyi, M.; Rudin, C. M.; Kris, M. G.; Riely, G. J.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing
    Journal Article

    Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations
    Meeting Abstract

    Riely, G. J.; Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save